Melanoma - Altai Oncology Software

Melanoma

New Drug: Tebentafusp in Metastatic Uveal Melanoma

Ulas D. Bayraktar, MD

Melanoma

New Indication: Perioperative Pembrolizumab in Melanoma

Ulas D. Bayraktar, MD

Melanoma

New Protocol: Atezolizumab with Vemurafenib and Cobimetinib in Metastatic Melanoma

Ulas D. Bayraktar, MD

Melanoma

New Drug: Relatlimab and Nivolumab for Advanced Melanoma

Ulas D. Bayraktar, MD

Melanoma

New Indication: Adjuvant Pembrolizumab for Melanoma

Ulas D. Bayraktar, MD

Back to top Drag